This paper is in the following e-collection/theme issue:

Drug Repurposing and Off-Label Use (25) Research Infrastructures and Registries (63) Innovations in Clinical Trials and Research Data Management (84) Secondary Use of Clinical Data for Research and Surveillance (376) Clinical Informatics (1050) Participatory Medicine & E-Patients (787)

Published on in Vol 23, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26890, first published .
ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study

ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study

ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study

Authors of this article:

Jan Borysowski1, 2 Author Orcid Image ;   Andrzej Górski3 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics

Jan Borysowski   1, 2 , MD, PhD ;   Andrzej Górski   3 , MD, PhD

1 Department of Clinical Immunology, Medical University of Warsaw, Warsaw, Poland

2 Centre for Studies on Research Integrity, Institute of Law Studies, Polish Academy of Sciences, Warsaw, Poland

3 Laboratory of Bacteriophages, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

Corresponding Author: